logo

For the Inventor, By the Inventor

Perkasie, PA, United States of America

Frank John Villani, Jr

This inventor holds 38 USPTO granted patents, plus 4 CIPO patents and 1 EPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Janssen Pharmaceutica Nv, Ortho-Mcneil Pharmaceutical Corp., Furiex Pharmaceuticals, Inc.. Active years: 1993-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frank John Villani, Jr. Retrieved from https://idiyas.com/inventor/frank-john-villani-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 38

% Patents Active = 76.3



Average Co-Inventor Count = 4.7

ph-index = 9

Forward Citations = 166(Granted Patents)


Company Filing History:

goldMedal18 out of 2,101 
 
Janssen Pharmaceutica Nv
 patents
silverMedal7 out of 363 
 
Ortho-Mcneil Pharmaceutical Corp.
 patents
bronzeMedal4 out of 4 
 
Furiex Pharmaceuticals, Inc.
 patents
4. 3 out of 189 
 
Mcneil Ab
 patents
5. 3 out of 377 
 
Ortho Pharmaceutical Corporation
 patents
6. 1 out of 11 
 
Allergan Holdings Unlimited Company
 patents
7. 1 out of 1 
 
Forest Tosara Limited
 patent
8. 1 out of 1 
 
Mcneil Pharmaceutical, Inc.
 patent

Years Active: 1993-2017

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Peptide Synthesis
Histamine Receptor Modulators
Anticonvulsant Derivatives
Pulmonary Surfactant
Sodium-Dependent Glucose Transporter
Arylsubstituted Piperazines
Chymase Modulators
Tetrahydroisoquinoline Derivatives
Benzotriazepine Derivatives
Substituted Pyridyl Amides
Heterocycles
3-Amino-3-Aryl Propanoates
38 patents (USPTO):Explore Patents
1. 9789125 - Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid (2017-10-17),
2. 9364489 - Crystals and process of making 5-({[2-amino-3-(4-Carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid (2016-06-14),
3. 9321729 - Substituted pyridyl amide compounds as modulators of the histamine H3 receptor (2016-04-26),
4. 9187408 - Process for the preparation of protected L-alanine derivatives (2015-11-17),
5. 9115091 - Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl—1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid (2015-08-25),
6. 8940731 - [object Object] (2015-01-27),
7. 8859604 - Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid (2014-10-14),
8. 8853445 - Process for the preparation of protected L-alanine derivatives (2014-10-07),
9. 8710256 - Process for the preparation of protected L-alanine derivatives (2014-04-29),
10. 8703948 - Salts of 3-(3-amino-2-(R)-hydroxy-propyl)-1-(4-fluoro-phenyl)-8-(8-methyl-naphthalen-1-ylmethyl)-1,3,8-triaza-spiro[4.5]decan-4-one (2014-04-22),
11. 8691860 - Crystals and process of making 5-({(2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(-4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid (2014-04-08),
12. 8637520 - [object Object] (2014-01-28),
13. 8609865 - Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid (2013-12-17),
14. 8378122 - Process for the preparation of chymase modulators (2013-02-19),
15. 8263785 - Process for the preparation of chymase modulators (2012-09-11),

Title: Innovations of Frank John Villani, Jr. in Pharmaceutical Patents

Introduction: Frank John Villani, Jr., based in Perkasie, PA, is an esteemed inventor with an impressive portfolio of 38 patents. His contributions primarily reside in the pharmaceutical industry, where his work focuses on novel compounds and their applications.

Latest Patents: Among his latest inventions, Frank has developed "Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid." This innovation pertains to the synthesis of a unique zwitterionic crystal form, which has significant implications for drug development and delivery.

Career Highlights: Frank has had a prominent career in the pharmaceutical sector, notably working with Janssen Pharmaceutica and Ortho-McNeil Pharmaceutical Corporation. His experience in these organizations underscores his expertise in pharmaceuticals and drug formulation.

Collaborations: Throughout his career, Frank has collaborated with notable individuals such as Luigi Anzalone and Cynthia Anne Maryanoff. These partnerships have likely contributed to his success in developing innovative solutions within the pharmaceutical field.

Conclusion: Frank John Villani, Jr. exemplifies the spirit of innovation within the pharmaceutical industry through his extensive patent portfolio and collaborations. His latest patents showcase his dedication to advancing drug formulation technologies, and his work continues to influence the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…